USA

Trump will sign order to reduce drug prices by up to 80 per cent

Ad on Truth to hug prices from 30% to 80%

 (Photo by SAUL LOEB / AFP)

2' min read

2' min read

Donald Trump declared his intention to sign an executive order to impose a sharp reduction in the cost of medicines in the United States, openly defying opposition from the pharmaceutical industry and reservations expressed by some leading members of the Republican Party.

In a post published Sunday evening on the Truth Social platform, the former president announced that he would sign the measure with the goal of lowering drug prices 'almost immediately, from 30% to 80%'. The US president said that on drugs Europe will have to pay a little more, the rest of the world will have to pay a little more, and the US will pay a little less'. Trump also announced the introduction of a 'most favoured nation' mechanism, whereby the US will pay the same price for drugs as the country where the cost is lowest globally.

Loading...

It is a proposal similar to the one already made during his first presidential term, which, however, did not materialise due to strong resistance from pharmaceutical companies.

Despite the campaign contributions he received from large pharmaceutical groups and trade associations for his inauguration ceremony, Trump said he would not be swayed. "Campaign donations can work wonders, but not with me and not with the Republican Party," he wrote. "We will do the right thing, something the Democrats have been trying to get for years."

The PhRMA association, which represents major companies in the industry, strongly criticised the proposal, stating that 'any form of government price control is detrimental to American patients'. The organisation added that the real problem that needs to be addressed to reduce the cost of drugs lies in the increasing share of spending that ends up in the hands of middlemen in the supply chain.

PhRMA had been one of the entities that had sued the previous Trump administration for attempting to introduce price containment measures, eventually leading the White House, under the leadership of Joe Biden, to abandon those proposals.

Subsequently, the Biden administration included a drug price negotiation clause in its Inflation Reduction Act, acting on a select group of ten drugs. The measure is estimated to save nearly $100 billion over a decade. This reform triggered a new wave of legal actions by the industry, which have so far been unsuccessful.

Pharmaceutical companies have also launched a media campaign to counter price containment initiatives, arguing that such policies penalise innovation and reduce investment in research.

Trump dismissed these arguments in his social message, stating that for years companies have justified the high costs with R&D expenses, charging 'for no reason' the highest price 'only to American fools'. He then concluded that, thanks to the upcoming executive order, 'our country will finally be treated fairly'.

According to rumours, the White House is trying to include a provision on cutting drug prices in the next budget bill, but has already run into opposition from some Republicans, including House Speaker Mike Johnson.

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti